Cenexi

Executive Summary

Cenexi is a Belgium-based contract development and manufacturing organization (CDMO) specializing in the sterile manufacturing of injectable products, including pre-filled syringes, vials, and ampoules. Founded in 2004, the company serves both biologics and small molecule clients, offering end-to-end services from early development to commercial production. With its focus on high-barrier sterile manufacturing, Cenexi is positioned to benefit from the growing demand for injectable drugs, particularly in biologics and complex generics. The CDMO sector continues to see strong tailwinds from outsourcing trends and the need for specialized capacity. However, as a private company, Cenexi's financial performance and pipeline visibility are limited, making it challenging to assess near-term momentum. Its relatively niche focus on sterile injectables differentiates it from larger, more diversified CDMOs, but also exposes it to concentration risk. Overall, Cenexi appears to be a solid player in a growing segment, though its lack of public disclosures constrains conviction.

Upcoming Catalysts (preview)

• Q4 2026Capacity expansion announcement for sterile manufacturing70% success
• Q2 2026Key long-term supply agreement with a major pharma50% success
• Q1 2027Regulatory approval for new manufacturing suite80% success